These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31405785)

  • 21. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Polymorphisms of Delta-Like 1 Homolog Influence the Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity.
    Fu Y; Liu T; Song J; Jiao L; Zhou J; Bai H; Zhao Z; Chen H; Wu T; Lyv M; Zhou Y; Ying B; Xu Y
    DNA Cell Biol; 2021 Feb; 40(2):231-238. PubMed ID: 33297832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.
    Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Aranda FM; Frías A; Visca M; Aidar O; Perés S; de Larrañaga GF
    J Gastroenterol Hepatol; 2013 Feb; 28(2):323-8. PubMed ID: 23190413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors.
    Bouazzi OE; Hammi S; Bourkadi JE; Tebaa A; Tanani DS; Soulaymani-Bencheikh R; Badrane N; Bengueddour R
    Pan Afr Med J; 2016; 25():167. PubMed ID: 28292129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
    Zhu J; Liu W; Zhang M; Lu L; Pan H; He X; Wang N; Yang M; Yi H; Tang S
    J Clin Pharm Ther; 2021 Oct; 46(5):1288-1294. PubMed ID: 34046917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
    An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. rs1800796 of the IL6 gene is associated with increased risk for anti-tuberculosis drug-induced hepatotoxicity in Chinese Han children.
    Li Y; Tang H; Qi H; Shen C; Sun L; Li J; Xu F; Jiao W; Yang X; Shen A
    Tuberculosis (Edinb); 2018 Jul; 111():71-77. PubMed ID: 30029918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil.
    Heinrich MM; Zembrzuski VM; Ota MM; Sacchi FP; Teixeira RL; Cabello Acero PH; Cunha GM; Souza-Santos R; Croda J; Basta PC
    Tuberculosis (Edinb); 2016 Dec; 101():15-24. PubMed ID: 27865386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of HNF4α and HNF4α-AS1 gene variants on the risk of anti-tuberculosis drugs-induced hepatotoxicity.
    Zhang J; Liu X; He H; Zhou W; Liu Y; Jiang P; Feng J; Zhou Y; Meng X; Deng F
    Ann Palliat Med; 2021 Nov; 10(11):11733-11744. PubMed ID: 34872298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.
    Chen X; Hao Z; Pan H; Liu W; Lu L; Zhang M; He X; Yi H; Tang S
    Fundam Clin Pharmacol; 2023 Aug; 37(4):858-867. PubMed ID: 36855016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
    Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population.
    Zhang C; Jiao L; Bai H; Zhao Z; Hu X; Wang M; Wu T; Peng W; Liu T; Song J; Zhou J; Li M; Lyv M; Zhang J; Chen H; Chen J; Ying B
    Infect Genet Evol; 2020 Apr; 79():104147. PubMed ID: 31857256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.
    Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Yang Z; Xia Y; Chen D; Zhan S
    J Clin Pharm Ther; 2015 Apr; 40(2):186-91. PubMed ID: 25308608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of ALDH1A1 gene polymorphisms associated with antituberculosis drug-induced liver injury in western Chinese Han population.
    Peng W; Zhao ZZ; Jiao L; Wu T; Chen H; Zhang CY; Song JJ; Liu TY; Wu LJ; Wang MJ; Chen J; Zhou Y; Ying BW
    Microbiol Immunol; 2021 Apr; 65(4):143-153. PubMed ID: 33527427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
    Bai H; Wu T; Jiao L; Wu Q; Zhao Z; Song J; Liu T; Lv Y; Lu X; Ying B
    J Clin Pharmacol; 2020 Mar; 60(3):361-368. PubMed ID: 31648372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China.
    Xu N; Yang JX; Yang J
    Eur J Hosp Pharm; 2022 Jul; 29(4):217-221. PubMed ID: 32989000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population.
    Pan H; Yang M; Lu L; Tao B; He X; Chen H; Yi H; Tang S
    Pharmacogenet Genomics; 2019 Jun; 29(4):84-90. PubMed ID: 30720667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Chen R; Wang J; Tang S; Zhang Y; Lv X; Wu S; Xia Y; Deng P; Ma Y; Tu D; Chen D; Zhan S
    Tuberculosis (Edinb); 2015 Jan; 95(1):68-74. PubMed ID: 25498879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).
    Xia YY; Hu DY; Liu FY; Wang XM; Yuan YL; Tu DH; Chen YX; Zhou L; Zhu LZ; Gao WW; Wang HY; Chen da F; Yang L; He PP; Li XT; He YJ; Sun F; Zhan SY
    BMC Public Health; 2010 May; 10():267. PubMed ID: 20492672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.